CClinicalTrials.gg
CompletedNCT06098859Updated Oct 25, 2023

Thoracic Epidural Analgesia and Bilateral Erector Spinae Plane Block on Postoperative Pain in Open Heart Surgeries

An interventional study of Thoracic epidural analgesia and Erector spinae plane block in Pain, Postoperative and Respiratory Complication, sponsored by Karadeniz Technical University. Completed at 1 site in Turkey. Open to participants aged 20 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Karadeniz Technical University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jan 2023, registered Oct 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
20 Years to 75 Years
Sex
All
01

Study summary

Postoperative pain negatively effects respiratory functions in open heart surgeries. The aim of the study is to compare the effects of thoracic epidural analgesia (TEA) and erector spinae plane block (ESPB) on postoperative pain and respiratory functions in patients undergoing open heart surgery with sternotomy

Read the detailed description

Thoracic epidural catheter was inserted to patients in Group T at the T4-T5 vertebra level before induction of general anesthesia. And then local anesthetic infusion was started until postoperative 48. hours.

Bilateral erector spinae plan block was applied with total 40 ml of local anesthetic solution to patients in Group E at the T4-T5 vertebra level before induction of general anesthesia.

The control group was infused with 1 mcg/kg/min fentanyl during the surgery. In the postoperative period, 1 g paracetamol was infused 4 times a day.

All patients underwent general anesthesia with the same method and medications.

Tramadol/diclofenac was administered to patients with a pain score (NRS) above 4. NRS and tidal volumes (TV) of the patients were measured at 0, 2, 6, 12, 24, 36 and 48. hours after extubation. Postoperative mechanical ventilation durations, intensive care unit and hospital stays, additional analgesic needs and respiratory complications of the patients were recorded.

02

Conditions studied

  • Pain, Postoperative
  • Respiratory Complication

Browse trials for

Keywords

  • Thoracic epidural analgesia
  • erector spinae plane block
  • heart surgery
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 93 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Karadeniz Technical University is the lead sponsor of 145 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Has ASA II-IV score
  • Having open heart surgery

Exclusion criteria

Exclusion Criteria:

  • Having a psychiatric illness
  • Using analgesic medication due to chronic pain
  • Uncooperative
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
93 participants (actual)

Study arms

  • Active comparator
    Thoracic epidural analgesia

    Thoracic epidural analgesia have been started preoperatively and coninuoed until postoperative 48 hours

    Procedure: Thoracic epidural analgesia

  • Active comparator
    Erector spinae plane block

    Erector spinae plane blockwas applied preoperatively

    Procedure: Erector spinae plane block

  • No intervention
    Intravenous opioid analgesia

    Intravenous opioid analgesia was administered during the surgery

Interventions

  • ProcedureThoracic epidural analgesia

    Thoracic epidural analgesia was started preoperatively and rest posoperative 48 hours

  • ProcedureErector spinae plane block

    Erector spinae plane block was applied preoperatively using local anesthetic

06

What researchers measure

Primary outcomes

  1. Postoperative pain

    Patients were asked about their pain levels. Rating done with VRS (Verbal Rating Scale). Pain levels were evaluated between 0 and 10 points. 0: No pain (the best)..... 10: Unbearable pain (the worst)

    Time frame: Postoperative 48 hours

  2. Respiratory functions

    Oxygen requirement:If more than 4 l/min oxygen support via face mask is required to maintain peripheral oxygen saturation (SpO2) above 90%, it is defined as oxygen requirement. Tachypnea:more than 20/min Fever: more than 37 C celcius Non invasive mechanical ventilation requirement:To patients whose breathing is impaired after extubation (who have tachypnea and have SpO2 less than 90% despite receiving oxygen support of more than 4 l/min oxygen support via face mask)

    Time frame: Postoperative 48 hours

Secondary outcomes

  1. Analgesic requirement. When the VRS was more than 4 points

    diclofenac (75 mg), tramadol (50mg)

    Time frame: Postoperative 48 hours

  2. Intensive care and hospital stay

    time for Intensive care and hospital (hours and days, respectively)

    Time frame: postoperative 30 days

07

Study locations

1 site
  • Engin Ertürk
    Ortahisar, Trabzon 61080, Turkey
08

References and documents

Individual participant data

Plan to share: Yes — all collected IPD

Supporting information: Study protocol, Sap, Icf, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06098859
Lead sponsor
Karadeniz Technical University
Responsible party
Engin Ertürk (Prof. Dr, Karadeniz Technical University) — Principal investigator
First posted
Oct 25, 2023
Start date
Jan 10, 2023
Primary completion
Aug 28, 2023
Completion
Sep 15, 2023
Last update
Oct 25, 2023

Study contacts

Engin Ertürk, Prof. Dr
principal investigator · Karadeniz Technical University, Medical Faculty, Anesthesiology and Intensive Care

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion